Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
465.60    6.00 (1.31%)
Bid:
465.70
Ask:
466.00
Spread: 0.30 (0.064%)
Market Cap: £5.80b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

Director/PDMR Shareholding and TVR

3 Jun 2024 07:06

RNS Number : 7533Q
Melrose Industries PLC
03 June 2024
 

Crystallisation of 2020 Melrose Employee Share Plan, Transfer of Treasury Shares, Notification of Transactions by Person Discharging Managerial Responsibility and Total Voting Rights

Melrose announces that the 2020 Melrose Employee Share Plan (the "2020 MESP") crystallised on 31 May 2024, with certain Awards being settled by the transfer from treasury of Ordinary Shares to participants and the grant of Nil Cost Options, with the balance being settled by cash payments in an amount sufficient to meet participants' income and other tax liabilities in accordance with the Plan Rules (the "Cash Settlement").

In order to satisfy its obligations arising from the 2020 MESP that will not be settled in cash for the purposes of meeting participants' income and other tax liabilities, Melrose has today transferred a total of 28,848,071 Ordinary Shares from treasury to participants.

In relation to the Cash Settlement, Awards which would otherwise have given rise to Melrose being obliged to transfer a total of 25,498,465 Ordinary Shares will instead be settled by cash payments for the purposes of meeting participants' income and other tax liabilities (which, for UK tax resident participants, will be paid direct to HMRC to settle the outstanding tax liability in relation to their Awards), in an amount equal to the closing middle market quotation of those Ordinary Shares on the date of this announcement.

In satisfaction of Peter Dilnot's entitlement under the 2020 MESP, 1,643,404 Ordinary Shares were today transferred to Peter Dilnot, 1,457,359 Ordinary Shares will be settled by a cash payment pursuant to the Cash Settlement (each of which are included in the figures above), and Nil Cost Options have been awarded to Peter Dilnot over 3,875,954 Ordinary Shares, exercisable in 2025 and 2026. 

The above transfers of Ordinary Shares from treasury to participants, Cash Settlement and Nil Cost Options satisfy all participants' outstanding entitlements under the 2020 MESP.

Peter Dilnot is a "person discharging managerial responsibility" as such term is defined in Article 3(1)(25) of the UK Market Abuse Regulation. The transfer of the Ordinary Shares to, and the grant of Nil Cost Options to Peter Dilnot were made outside a trading venue. The ISIN number of the Ordinary Shares is GB00BNGDN821.

In accordance with the FCA's Disclosure Guidance and Transparency Rules (the "DTRs"), the Company announces that (following the transfers detailed above in connection with the 2020 MESP and the buyback transaction announced by the Company earlier this morning) its issued share capital now consists of 1,328,782,204 Ordinary Shares (excluding treasury shares), with each Ordinary Share carrying the right to one vote. The total number of Ordinary Shares held by the Company in treasury (following the transfers detailed above in connection with the 2020 MESP and the buyback transaction announced by the Company earlier this morning) is 22,693,117, which attract no voting rights whilst so held. Therefore, the total number of voting rights in Melrose as at 3 June 2024 is 1,328,782,204, which figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Melrose under the DTRs.

Unless otherwise defined, terms used in this announcement shall have the same meanings as set out in the circulars to Shareholders dated 21 January 2021 and 3 March 2023 respectively.

 

Enquiries:

 

Investor Relations:

Chris Dyett: +44 (0) 7974 974 690, ir@melroseplc.net

 

Montfort Communications: +44 (0) 20 3514 0897

Nick Miles: +44 (0) 7739 701 634, miles@montfort.london

Charlotte McMullen: +44 (0) 7921 881 800, mcmullen@montfort.london

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQKBBDBBKBOAK
Date   Source Headline
8th Jun 202612:25 pmRNSTR1 - Notification of Major Holdings
8th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20269:07 amRNSTR-1: Standard Form-Notification of Major Holdings
1st Jun 20269:02 amRNSTR1 - Notification of major holdings
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 202610:34 amRNSTR-1: Notification of major holdings
27th May 20264:26 pmRNSPDMR Announcement
27th May 20268:32 amRNSUpdate on Garden Grove facility in California
26th May 20267:09 amRNSOngoing incident at Garden Grove facility
26th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTR-1: Standard Form-Notification of Major Holdings
18th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTR-1: Standard form for notification
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20269:36 amRNSNotifications of Transactions of PDMR
5th May 20264:43 pmRNSNotifications of Transactions of PDMR
5th May 20264:23 pmRNSTransaction in Own Shares
5th May 20267:00 amRNSDirector Change / CFO Appointment
1st May 20268:26 amRNSDirector/PDMR Shareholding
29th Apr 20262:15 pmRNSResults of AGM
29th Apr 20267:00 amRNSAGM TRADING UPDATE
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20269:18 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 202611:09 amRNSNotifications of Transactions of PDMR
23rd Mar 20264:05 pmRNSAnnual Report and Notice of Annual General Meeting
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20269:52 amRNSNotification of Transactions of PDMR
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20263:19 pmRNSNotification of Transactions of PDMR
4th Mar 20267:00 amRNSNotification of Transactions of PDMR
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 202610:39 amRNSTR-1: Standard Form-Notification of Major Holdings
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:12 amRNSDirector Declaration - 2nd March 2026
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSFINAL RESULTS
27th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.